Teva Investigational Site 1319 — Ponte Vedra, Florida

Teva Investigational Site 1319 is a clinical research site located in Ponte Vedra, Florida, United States 32082.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Teva Investigational Site 1319 has participated in 1 clinical trials.

Therapeutic areas: Relapsing Remitting Multiple Sclerosis.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 1319?

Teva Investigational Site 1319 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 1319 conducted?

Teva Investigational Site 1319 has 1 clinical trials on record. Their work covers Relapsing Remitting Multiple Sclerosis.

Is Teva Investigational Site 1319 accredited by Crixeo Health?

Teva Investigational Site 1319 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 1319?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.